FreedomPay Launches ‘Donation on Device’ to Boost Charitable Giving

FreedomPay

PHILADELPHIA, PAFreedomPay has unveiled a new platform feature aimed at bolstering charitable donations directly through point-of-sale systems. The initiative, named Donation on Device, allows consumers to contribute to charitable causes effortlessly while making purchases. This innovation aligns with FreedomPay’s longstanding commitment to leveraging its technological prowess for philanthropic endeavors.

The Cancer Support Community (CSC) is FreedomPay’s founding partner for this initiative. CSC is a prominent global organization dedicated to supporting individuals impacted by cancer through various services, including navigation, insights, and advocacy.

Consumer Trends in Charitable Giving

Recent data from Engage for Good highlights the significant potential of point-of-sale fundraising. American retailers collected $749 million in consumer donations in 2022, marking a 24% increase from 2020. The study, which surveyed nearly 1,400 adults, found that 53% of respondents had made a donation during checkout in the past year. These figures suggest a growing consumer inclination towards charitable giving at retail points.

FreedomPay’s Donation on Device taps into this trend, offering a seamless method for consumers to donate. The initiative leverages the company’s DecisionPoint Network™, a digital advertising platform with nearly one million screens worldwide. This network enables merchants to prompt donations at the point-of-sale, increasing both contributions and awareness for charities.

Company and Partner Statements

“At FreedomPay, we are proud to support global charities and we are excited to introduce an easy way for merchants and customers to get involved,” said Tom Durovsik, Founder & CEO of FreedomPay. “By launching Donation on Device, we are able to bring an impactful change to charitable causes across the world. All merchants on the FreedomPay Platform will have an opportunity to participate and are learning about the initiative now.”

READ:  Revolutionizing Retail: Cantaloupe’s Smart Stores Tackle Theft, Labor Shortages, and Expand Possibilities

Sally Werner, CEO of CSC, expressed her gratitude for the partnership. “We are honored to have been selected as a founding partner. For over 20 years, FreedomPay has supported CSC’s mission to serve people coping with a cancer diagnosis in numerous ways that have made a tangible positive difference in the lives of countless individuals and families.”

Empowering Change: FreedomPay’s Donation on Device Initiative

The launch of Donation on Device comes at a critical time. According to the National Cancer Institute, there are approximately 18.1 million cancer survivors in the United States as of January 2022, with this number expected to rise. The increasing population of survivors and those affected by cancer underscores the need for robust support systems.

CSC plays a vital role in this ecosystem by providing professionally led support services, social connections, and education at no cost to those in need. The Donation on Device program will help CSC sustain and expand its offerings, ensuring that more individuals can access the resources they require.

From an industry perspective, FreedomPay’s initiative represents a significant advancement in integrating charitable giving with everyday transactions. By making it easier for consumers to donate, the company not only enhances its value proposition but also fosters a culture of giving within the retail environment. This approach could inspire other companies to adopt similar models, amplifying the impact across various causes.

FreedomPay’s launch of Donation on Device marks a pivotal step in harnessing technology for social good. By enabling easy point-of-sale donations, the company supports vital organizations like the Cancer Support Community while tapping into a growing trend of consumer-driven philanthropy. As more merchants join the initiative, the potential for widespread positive impact increases, benefiting communities and individuals worldwide.

READ:  Endo, Inc. Launches FDA-Approved ADRENALIN® Premixed Epinephrine Bag

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.